Hyperbolic Tapering Explained: Why Slow and Steady Wins

Hyperbolic tapering means sizing each dose reduction so that every step produces roughly the same change in receptor occupancy, which in practice means cutting a fixed percentage of your current dose rather than a fixed number of milligrams. A 10 percent cut of your current dose shrinks in absolute size at every step: after 10 steps you are at about 35 percent of where you started, and each cut is now less than half the size of the first one. The reason this matters is that the brain does not respond to dose in a straight line. Hyperbolic tapering is the approach now supported by the strongest evidence in the deprescribing literature, and it explains why so many tapers fall apart at the very end rather than at the beginning.

Why cutting by equal milligrams stops working

When someone says "I am tapering 10 percent every month," they usually mean 10 percent of the original dose, subtracted again and again. That is linear tapering, and on paper it looks orderly.

The brain does not cooperate with that arithmetic. The relationship between how much drug you take and how many receptors that drug occupies follows a hyperbolic curve, a dose-response relationship that has been established in pharmacology for decades. The first milligrams of a drug produce a large change in receptor occupancy. Later milligrams produce progressively smaller additional effects.

For fluoxetine (Prozac), a standard 20 mg dose occupies roughly 80 percent of serotonin transporters, and halving it to 10 mg drops occupancy only to about 60 percent. Going from 2 mg to zero produces a similar 20 point shift in occupancy while removing just 2 mg of drug. The absolute dose change gets much smaller near the bottom, but the neurological impact of each step stays about the same.

This is why people who have cut down to 1 mg or 2 mg still report significant withdrawal. They are not unusually sensitive or imagining it. Their nervous system is absorbing a receptor-level change comparable to far larger cuts made at the top of the dose range.

Bottom line: milligrams are a poor unit of measurement for withdrawal, because equal milligram cuts are not equal neurological cuts.

Hyperbolic vs linear tapering

Linear tapering subtracts the same amount every step. Hyperbolic tapering subtracts the same proportion of what you are currently taking, so the absolute size of each cut falls as you descend.

Dimension	Linear tapering	Hyperbolic tapering
How each cut is sized	Fixed number of milligrams, set from the starting dose	Fixed percentage of the current dose
Change in receptor occupancy per step	Small at the top, very large at the bottom	Roughly even across the whole taper
Where trouble usually appears	The final third, often below 25 percent of the starting dose	Spread evenly, and generally milder
Number of steps required	Few	Many, especially in the low range
Formulations needed	Whole and half tablets	Liquid, compounded doses, or titration for the low end
Best for	People stopping after a few weeks of treatment, where physical dependence is minimal	Anyone on the drug for months or years, and anyone who has already had withdrawal symptoms

The honest downside of hyperbolic tapering is that it takes longer and demands precision that standard tablets cannot deliver. Linear tapering is faster and needs no special equipment, which is exactly why prescribers default to it. The trade is speed against stability, and for long-term users the evidence favors stability.

Choose linear tapering if you have been on the medication a short time, at a low dose, and have never felt withdrawal from a missed dose. Choose hyperbolic tapering if you have taken the drug for more than six months, have felt symptoms after a missed dose or a previous reduction, or have failed a taper before.

Bottom line: linear tapering accelerates without telling you, and hyperbolic tapering holds the pace steady where your nervous system actually measures it.

What a hyperbolic taper looks like as a percentage of your starting dose

Hyperbolic tapering is easiest to read as a percentage of where you began, because the percentages are the same no matter which drug or dose you started on. The table below shows a taper that removes 10 percent of the current dose at each step.

Step	Percent of starting dose	Size of that cut, as a percent of the starting dose
Start	100%	n/a
1	90%	10.0%
2	81%	9.0%
3	73%	8.1%
4	66%	7.3%
6	53%	5.9%
8	43%	4.8%
10	35%	3.9%
15	21%	2.3%
20	12%	1.4%

Read the third column, not the second. By step 20 each reduction is removing about 1.4 percent of the original dose, roughly a seventh of the size of the first cut, and yet it asks the same adjustment of the brain. That shrinking curve is the entire point of the method.

Deliberately absent from that table are milligrams. The right percentage, the right interval, and the right starting point depend on your drug, your history, and how you respond, which is why this site publishes principles rather than a numbered schedule to copy. To turn percentages into a plan for your own dose, the taper planner does the arithmetic and shows the occupancy curve alongside it.

The term "hyperbolic" describes the mathematical shape of the occupancy curve. Nothing about the method is extreme or exaggerated.

Bottom line: a hyperbolic taper is a fixed percentage of the current dose, repeated, which produces cuts that get smaller in absolute terms all the way down.

The 10 percent rule vs hyperbolic tapering

The "10 percent rule" is the most common piece of tapering advice online, and it means two completely different things depending on what the 10 percent is taken from.

Question	10 percent of the starting dose	10 percent of the current dose
What gets subtracted	The same amount every time	A shrinking amount every time
Shape of the schedule	Linear	Hyperbolic, or very close to it
Steps to reach zero	10, with the last one a full jump off	Many, approaching zero gradually
Change in occupancy near the bottom	Enormous on the final steps	Comparable to every earlier step
Matches the pharmacology	No	Yes
Best for	Short-term users tapering from a low dose	Long-term users, and anyone with prior withdrawal

Taken as 10 percent of the current dose, the rule is a reasonable approximation of hyperbolic tapering and needs no modeling software to follow. Its limitation is that 10 percent is an average, not a personal number: some people need 5 percent steps, and some tolerate more. A fuller treatment of where the rule came from and when it fails is in the guide to the 10 percent tapering rule.

Bottom line: 10 percent of the current dose approximates hyperbolic tapering well, 10 percent of the starting dose does not, and the two get confused constantly.

The Horowitz and Taylor research behind hyperbolic tapering

The pharmacological case for hyperbolic tapering in psychiatry was made by Mark Horowitz and David Taylor in a 2019 paper in Lancet Psychiatry, "Tapering of SSRI treatment to mitigate withdrawal symptoms", which used receptor occupancy modeling to show that SSRI dose and serotonin transporter occupancy are related hyperbolically rather than linearly.

Applying that model to the serotonin transporter, Horowitz and Taylor showed that reducing fluoxetine from 20 mg to 10 mg produces a change in occupancy comparable to reducing from 2 mg to 1 mg. The paper challenged the widely repeated advice to taper over two to four weeks, which had no pharmacological basis, and argued that reductions should be calibrated to receptor occupancy instead of raw milligrams. A deeper walkthrough of the modeling sits in the article on Horowitz and Taylor's hyperbolic tapering research.

That work moved into guidance. The UK's NICE guideline on medicines associated with dependence and withdrawal now tells prescribers to reduce antidepressants in steps proportionate to the current dose, with slower steps at low doses, and the 2024 Maudsley Deprescribing Guidelines, written by Horowitz and Taylor with colleagues, set out hyperbolic protocols drug by drug along with instructions for liquids, compounding, and titration.

The same principle extends to benzodiazepines through different receptor dynamics. Professor Heather Ashton's work at Newcastle University, compiled as the Ashton Manual, described individualized gradual benzodiazepine tapers decades before hyperbolic tapering was discussed for antidepressants, and its emphasis on pace over method aligns closely with the hyperbolic framework. The broader case for proportional reductions across drug classes is also set out by the clinician network at Deprescribing.org.

Bottom line: hyperbolic tapering is not a community theory, it is modeled pharmacology that has already reached national prescribing guidance.

Why the last few milligrams of an antidepressant are the hardest

The most common taper story is that the first cuts passed almost unnoticed and the final stretch was punishing. Hyperbolic tapering predicts exactly that pattern.

Dropping an SSRI from 20 mg to 10 mg moves serotonin transporter occupancy from roughly 80 percent to roughly 60 percent, a 20 point shift. Dropping from 2 mg to zero moves occupancy from roughly 20 percent to zero, another 20 point shift. One is a halving of dose and the other is the elimination of a dose most prescribers would call negligible, and the nervous system registers them as similar events.

If you have been cutting by a fixed number of milligrams, your pace quietly accelerated as you descended. The last steps asked your brain to absorb larger neurological changes in the same amount of time as the early ones, which is a schedule problem rather than a willpower problem.

Reframing this matters clinically. Difficulty at low doses is regularly misread, by patients and prescribers alike, as proof that the original condition is returning or that the person is psychologically dependent. Withdrawal severity at 1 mg is far better explained by an uncalibrated schedule, and switching to a hyperbolic approach partway through a taper often restores stability without any return to the starting dose.

Bottom line: the end of a taper is the hardest part because a milligram-based schedule speeds up precisely when the brain needs it to slow down.

How to plan a hyperbolic taper

A precise calculation needs the dose-occupancy curve for your specific medication, which has been modeled for common SSRIs and SNRIs and is less established elsewhere. The workable general rule is to reduce by a fixed percentage of your current dose at every step, commonly in the range of 5 to 10 percent, and to never reset that percentage against the original dose.

Intervals matter as much as step size. The pace between reductions is a separate variable from the size of each cut, and hyperbolic tapering only addresses the second one. Clinicians working with this approach generally suggest holding each new dose for at least two to four weeks, and longer whenever symptoms are still present, because the nervous system adapts on its own schedule.

Getting the doses themselves is the practical bottleneck. Several medications have approved oral solutions, and the FDA's Drugs@FDA labeling database shows which formulations exist for a given drug. Compounding pharmacies can prepare smaller doses to order. Liquid titration covers the rest, and tablet splitting works only at the top of the range, where a small error is a small proportion of the dose.

Writing the plan down before starting is worth the hour it takes. The tapering plan worksheet walks through step size, hold length, and what you will do if a step goes badly, decided in advance rather than during a bad week.

Bottom line: pick a percentage of current dose, pick a minimum hold length, secure a formulation that can actually deliver the doses, and write it down before the first cut.

What withdrawal symptoms tell you about your tapering pace

Hyperbolic tapering lowers the odds of severe or prolonged withdrawal without eliminating symptoms. When symptoms do appear after a reduction, they are information about pace rather than evidence of failure: the cut was too large, the interval too short, or both.

Common discontinuation symptoms include dizziness, flu-like aching, irritability, insomnia, electric shock sensations often called brain zaps, and emotional volatility. These overlap heavily with anxiety and depression, which is what makes withdrawal so easy to misdiagnose as relapse. Horowitz and Taylor address the distinction directly: withdrawal typically begins within days of a dose change and resolves over weeks, while relapse usually builds more slowly and reproduces the full original illness rather than introducing new physical symptoms.

When symptoms are significant, the usual response is to hold at the current dose until they settle, or to return to the last dose that felt stable and wait there before continuing. Pushing through by holding for a day or two and cutting again tends to stack instability rather than resolve it. Patient accounts collected at Surviving Antidepressants describe this pattern repeatedly, and it is the single most common way a taper goes off the rails.

Bottom line: symptoms after a cut are a signal to hold or stabilize, not a signal to push harder.

Practical barriers to hyperbolic tapering and how people work around them

The main obstacle is that medication is not manufactured for this. A 10 mg tablet does not divide cleanly into 0.5 mg pieces, which creates a genuine access problem for people who cannot afford compounding or whose prescriber has never heard of the method.

Approved liquid formulations solve it where they exist. Fluoxetine is sold as a 20 mg per 5 mL oral solution in many countries, which makes very small reductions straightforward with an oral syringe and no compounding at all. Sertraline (Zoloft) also has an approved oral concentrate. Where no liquid exists, clinician-supervised compounding is the most reliable route.

Water titration fills the gap using kitchen equipment: dissolve a tablet in a measured volume of water, shake it thoroughly, then take a measured portion and discard the rest. The method allows reductions down to the millilitre and has been used successfully for many drugs that disperse reasonably well. It does not work for extended-release formulations such as venlafaxine (Effexor) XR, and it is not precise enough for every scenario.

Finding a prescriber who already understands proportional tapering is the last barrier, and often the hardest. The Maudsley Deprescribing Guidelines and the NICE guidance are both citable in an appointment, and coverage of the research at Mad in America has made the argument familiar to a growing number of clinicians. Leading with the published evidence tends to work better than asking a doctor to endorse a position.

Bottom line: liquids, compounding, and titration each solve part of the formulation problem, and printed guidelines are the most effective way to bring a prescriber along.

I have been cutting 10 percent of my original dose every month and I feel awful. What should I do?

Stop cutting and hold at your current dose. Symptoms that arrive after each reduction and have been getting worse as the dose falls are the signature of a linear schedule running past what your nervous system can absorb, and adding another cut on schedule will compound it.

Hold until symptoms settle and you have had a stable stretch, usually a minimum of two to four weeks and often considerably longer. If symptoms are severe and started shortly after a recent reduction, returning to the last dose where you felt stable is a reasonable step to discuss with your prescriber, and stability generally returns faster than people expect.

Then restart with the percentage measured against your current dose, not your original one, and cut the percentage itself if 10 percent was more than you could handle. There is no requirement to go back to your starting dose, and no ground is lost by recalculating from where you now stand.

Bottom line: hold, stabilize, then resume with a percentage of your current dose and a longer interval than the one that failed.

Frequently asked questions

Is hyperbolic tapering only for antidepressants?

The underlying pharmacology applies broadly, though the receptor occupancy modeling is most developed for SSRIs and SNRIs. Benzodiazepines act through allosteric modulation of GABA-A receptors rather than transporter blockade, but the same logic holds: the last milligrams carry outsized neurological weight and reductions should shrink in absolute size as the dose falls. The Ashton Manual provides the equivalent framework for benzodiazepines.

How is hyperbolic tapering different from the 10 percent method?

It depends entirely on what the 10 percent is measured against. Ten percent of the original dose, subtracted repeatedly, is linear and ignores the hyperbolic curve. Ten percent of the current dose produces a shrinking cut at every step and approximates hyperbolic tapering closely. The difference is negligible at the top of a taper and decisive at the bottom.

How long does a full hyperbolic taper take?

The honest answer is longer than most people want to hear, and the range is wide: months for someone on a low dose for a short time, one to two years or more for someone who has taken the drug for years. That compares against a fast taper followed by months of severe withdrawal, which is not actually the faster route to being off the drug.

I am down to my last milligram and my doctor says to just stop. Is that safe?

For many long-term users it is the single riskiest step in the taper, because that final milligram can still carry 15 to 20 percentage points of receptor occupancy. The pharmacology says the last stretch needs the smallest steps and the longest holds, not a jump. This is the point where an oral solution or a compounded dose earns its cost, and where the published occupancy modeling is most useful to show a prescriber.

Can I switch to a hyperbolic approach partway through a taper?

Yes, and mid-taper is when most people discover the method. Stabilize at your current dose until symptoms have resolved, which can take several weeks, then recalculate every subsequent step as a percentage of that dose. Returning to your original dose is not required.

Do I need a compounding pharmacy to taper hyperbolically?

Not always. Approved liquid formulations, water titration, and careful tablet splitting cover most of the dose range, particularly at the top where precision matters least. Below roughly 1 to 2 mg for most medications, a compounded preparation or a commercial liquid usually becomes necessary to make cuts small enough to follow the schedule.

Conclusion

Hyperbolic tapering follows from the pharmacology of the drugs themselves, and it now sits in national prescribing guidance rather than at the edges of the conversation. If your taper has been hardest at the lowest doses, the most likely explanation is the schedule rather than your capacity to tolerate change, and recalculating each step against your current dose is a change you can make today.

taper.community is a free peer forum and resource library for people coming off psychiatric medication, built around hyperbolic tapering and slow, proportional dose reductions. Members compare notes on titration, compounding, hold lengths, and the long middle stretch of a taper, and questions from people partway through a difficult reduction are welcome.

---

This article is for informational purposes only and does not constitute medical advice. Medication changes should always be made with the guidance of a qualified healthcare provider who can assess your individual circumstances.